agilon health (NYSE:AGL) Shares Up 5.6% Following Analyst Upgrade

agilon health, inc. (NYSE:AGL - Get Free Report) shares traded up 5.6% during trading on Thursday after Royal Bank of Canada raised their price target on the stock from $3.00 to $3.50. Royal Bank of Canada currently has an outperform rating on the stock. agilon health traded as high as $3.58 and last traded at $3.55. 318,263 shares traded hands during mid-day trading, a decline of 94% from the average session volume of 5,431,873 shares. The stock had previously closed at $3.36.

Several other research firms have also commented on AGL. Needham & Company LLC reaffirmed a "hold" rating on shares of agilon health in a research report on Wednesday, February 26th. Macquarie started coverage on agilon health in a research report on Monday, December 16th. They issued a "neutral" rating and a $3.00 price target for the company. Citigroup upgraded agilon health from a "sell" rating to a "neutral" rating and boosted their price objective for the company from $1.75 to $2.25 in a research note on Friday, January 10th. William Blair downgraded shares of agilon health from an "outperform" rating to a "market perform" rating in a report on Friday, November 8th. Finally, JMP Securities downgraded shares of agilon health from an "outperform" rating to a "market perform" rating in a report on Monday, November 11th. Two equities research analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Hold" and an average price target of $3.95.

Insiders Place Their Bets

In other news, Director John William Wulf acquired 45,000 shares of agilon health stock in a transaction that occurred on Thursday, December 5th. The shares were bought at an average cost of $2.18 per share, with a total value of $98,100.00. Following the transaction, the director now directly owns 206,133 shares of the company's stock, valued at $449,369.94. This trade represents a 27.93 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at this link. Also, Director Karen Mcloughlin purchased 25,000 shares of the business's stock in a transaction dated Friday, December 13th. The stock was bought at an average price of $2.20 per share, for a total transaction of $55,000.00. Following the completion of the acquisition, the director now owns 73,166 shares of the company's stock, valued at approximately $160,965.20. The trade was a 51.90 % increase in their position. The disclosure for this purchase can be found here. Insiders have purchased 77,500 shares of company stock valued at $169,600 over the last ninety days. 3.20% of the stock is owned by insiders.

Institutional Investors Weigh In On agilon health

A number of institutional investors and hedge funds have recently bought and sold shares of the company. Vanguard Group Inc. grew its holdings in agilon health by 0.9% during the 4th quarter. Vanguard Group Inc. now owns 31,112,407 shares of the company's stock worth $59,114,000 after acquiring an additional 272,787 shares in the last quarter. Capital International Investors lifted its position in shares of agilon health by 72.0% during the fourth quarter. Capital International Investors now owns 22,331,873 shares of the company's stock valued at $42,431,000 after buying an additional 9,346,295 shares during the last quarter. State Street Corp boosted its holdings in shares of agilon health by 3.0% in the 3rd quarter. State Street Corp now owns 7,449,706 shares of the company's stock valued at $29,277,000 after buying an additional 215,733 shares in the last quarter. Millennium Management LLC raised its stake in shares of agilon health by 187.8% during the 4th quarter. Millennium Management LLC now owns 7,212,525 shares of the company's stock worth $13,704,000 after acquiring an additional 4,706,357 shares in the last quarter. Finally, Geode Capital Management LLC lifted its position in agilon health by 0.5% during the fourth quarter. Geode Capital Management LLC now owns 6,928,724 shares of the company's stock valued at $13,168,000 after acquiring an additional 35,207 shares during the last quarter.

agilon health Trading Down 4.5 %

The company's 50 day simple moving average is $2.96 and its two-hundred day simple moving average is $2.99. The company has a market capitalization of $1.23 billion, a price-to-earnings ratio of -3.17 and a beta of 0.67. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.